Kleinfeld Kaplan & Becker LLP Announces Election of Samantha N. Hong as Partner

Kleinfeld Kaplan & Becker LLP (KKB) is pleased to announce that Samantha N. Hong has been elected to the partnership effective January 1, 2024. Ms. Hong’s practice focuses on advising and representing clients regulated by the U.S. Food and Drug Administration (FDA) in the pharmaceutical, food, dietary supplement, tobacco, cosmetic, and medical device industries on regulatory compliance and advertising law matters.

Prior to joining KKB as an associate in 2021, she served as Associate Chief Counsel at FDA’s Office of the Chief Counsel, where she worked closely with the U.S. Department of Justice to represent the agency in major enforcement actions regarding violations of the Federal Food, Drug, and Cosmetic Act and to defend challenges to agency actions on issues ranging from drug exclusivity to tobacco product policies. She also previously served in the Office of the General Counsel at the U.S. Department of Health & Human Services (HHS), where she advised various HHS components including the Office of Research Integrity and the National Vaccine Program Office. Prior to her government service, Ms. Hong practiced patent litigation at large international law firms.

“Samantha’s diverse set of skills and experiences position her exceptionally well for making significant contributions to the partnership and the broader FDA bar for many years,” said Dan Dwyer, KKB’s managing partner. “Her promotion will strengthen our firm’s position among the most comprehensive FDA regulatory and advertising practices in the country.”

Ms. Hong earned her J.D. from Harvard Law School and M.P.H. from the Harvard T.H. Chan School of Public Health. She is a member of the bars of the District of Columbia and New York. Ms. Hong can be reached at or (202) 223-5120.

Kleinfeld Kaplan & Becker LLP is a Washington DC boutique law firm that has focused on food-and-drug and advertising law issues for over 60 years. The firm’s practice concentrates on the regulation of products subject to the jurisdiction of the U.S. Food and Drug Administration — food, drugs & biologics, cosmetics, medical devices, dietary supplements, and tobacco products — as well as advertising laws and other laws regulating consumer products and services. The practice also covers many related areas, including: regulation of controlled substances; meat, poultry, and egg products; Medicare and Medicaid reimbursement, price reporting, and compliance issues; unfair trade practice investigations; alcoholic beverages; and cannabis. For more information, visit www.kkblaw.com.